Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA's ODAC recommends approval of Mylotarg for relapsed AML

March 21, 2000

Picower Institute presents new immunotherapeutic anticancer agents

March 17, 2000

Antisoma takes up another product from ICRF for clinical development

March 17, 2000

Low-dose M-Vax shows promise in stage III metastatic melanoma

March 17, 2000

Seattle Genetics updates MAb program

March 17, 2000

IND filed by NeoPharm for glioblastoma treatment

March 16, 2000

OvaRex shows evidence of cellular immune response

March 14, 2000

The FDA approves Pacis immunotherapy for treatment of bladder cancer

March 13, 2000

SciClone's Zadaxin boosts immune recognition of tumor cells

March 8, 2000

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...